Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AKYA Akoya Biosciences	$1.29	$1.28	$0.93 ▼ $3.42	$64.44M	1.36	416,191 shs	N/A
FEIM Frequency Electronics	$31.29 +7.3%	$23.08	$11.56 ▼ $31.38	$283.76M	0.45	410,003 shs	325,973 shs
KEQU Kewaunee Scientific	$56.50 +2.8%	$51.05	$30.33 ▼ $71.33	$162M	0.7	10,719 shs	17,173 shs
MASS 908 Devices	$6.47 +0.6%	$6.89	$1.81 ▼ $8.06	$230.59M	0.37	295,746 shs	246,055 shs

Reduce the Risk

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AKYA Akoya Biosciences	0.00%	0.00%	0.00%	+27.09%	-41.36%
FEIM Frequency Electronics	-1.22%	+5.19%	+48.52%	+63.88%	+145.33%
KEQU Kewaunee Scientific	+3.72%	-0.74%	-7.05%	+46.59%	+20.76%
MASS 908 Devices	+1.58%	-1.38%	-7.35%	+38.28%	+47.82%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AKYA Akoya Biosciences	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FEIM Frequency Electronics	1.4307 of 5 stars	0.0	2.0	0.0	0.0	3.1	2.5	1.3
KEQU Kewaunee Scientific	1.3328 of 5 stars	0.0	3.0	0.0	0.0	2.7	1.7	1.3
MASS 908 Devices	3.0209 of 5 stars	2.6	4.0	0.0	0.0	1.9	5.0	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AKYA Akoya Biosciences	2.00	Hold	$2.38	84.69% Upside
FEIM Frequency Electronics	0.00	N/A	N/A	N/A
KEQU Kewaunee Scientific	0.00	N/A	N/A	N/A
MASS 908 Devices	3.25	Buy	$8.00	23.65% Upside

Current Analyst Ratings Breakdown

Latest AKYA, FEIM, MASS, and KEQU Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/5/2025	MASS 908 Devices	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
8/5/2025	MASS 908 Devices	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Market Perform ➝ Outperform	$12.00
7/29/2025	MASS 908 Devices	Weiss Ratings Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell (D-) ➝ Sell (D-)
7/12/2025	MASS 908 Devices	Weiss Ratings Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell (D-) ➝ Sell (D-)
6/27/2025	MASS 908 Devices	Weiss Ratings Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell (D-) ➝ Sell (D-)
6/11/2025	MASS 908 Devices	Weiss Ratings Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell (E+) ➝ Sell (D-)
5/24/2025	MASS 908 Devices	Weiss Ratings Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell (D-) ➝ Sell (E+)
5/19/2025	AKYA Akoya Biosciences	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Hold ➝ Hold	$1.80 ➝ $1.08

(Data available from 8/12/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AKYA Akoya Biosciences	$79.96M	0.81	N/A	N/A	$0.15 per share	8.60
FEIM Frequency Electronics	$69.81M	4.36	$2.87 per share	10.92	$5.75 per share	5.44
KEQU Kewaunee Scientific	$240.47M	0.69	$7.55 per share	7.48	$23.21 per share	2.43
MASS 908 Devices	$59.63M	3.89	N/A	N/A	$4.15 per share	1.56

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AKYA Akoya Biosciences	-$55.37M	-$0.97	N/A	N/A	N/A	-59.44%	-487.85%	-35.86%	N/A
FEIM Frequency Electronics	$23.69M	$2.47	12.67	∞	N/A	34.09%	53.83%	27.82%	9/9/2025 (Estimated)
KEQU Kewaunee Scientific	$11.40M	$3.83	14.75	∞	N/A	4.74%	26.02%	9.87%	9/10/2025 (Estimated)
MASS 908 Devices	-$72.21M	-$0.54	N/A	N/A	N/A	-30.54%	-24.30%	-18.55%	N/A

Latest AKYA, FEIM, MASS, and KEQU Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/9/2025	Q1 2026	FEIM Frequency Electronics	$0.36	N/A	N/A	N/A	$16.53 million	N/A
8/5/2025	Q2 2025	MASS 908 Devices	-$0.16	-$0.18	-$0.02	-$0.37	$12.17 million	$4.70 million
7/10/2025	Q4 2025	FEIM Frequency Electronics	N/A	$0.34	N/A	$0.34	N/A	$19.99 million
6/25/2025	Q4 2025	KEQU Kewaunee Scientific	N/A	$1.95	N/A	$1.63	N/A	$77.15 million
5/13/2025	Q1 2025	MASS 908 Devices	-$0.27	-$0.22	+$0.05	$1.23	$11.90 million	$11.78 million
5/12/2025	Q1 2025	AKYA Akoya Biosciences	-$0.29	-$0.32	-$0.03	-$0.32	$20.19 million	$16.64 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AKYA Akoya Biosciences	N/A	N/A	N/A	N/A	N/A
FEIM Frequency Electronics	N/A	N/A	N/A	N/A	N/A
KEQU Kewaunee Scientific	N/A	N/A	N/A	N/A	N/A
MASS 908 Devices	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AKYA Akoya Biosciences	10.12	0.61	0.40
FEIM Frequency Electronics	N/A	2.26	1.26
KEQU Kewaunee Scientific	0.92	2.20	1.59
MASS 908 Devices	N/A	4.98	4.46

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AKYA Akoya Biosciences	79.42%
FEIM Frequency Electronics	58.60%
KEQU Kewaunee Scientific	32.69%
MASS 908 Devices	88.06%

Insider Ownership

Company	Insider Ownership
AKYA Akoya Biosciences	7.30%
FEIM Frequency Electronics	26.10%
KEQU Kewaunee Scientific	13.30%
MASS 908 Devices	23.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AKYA Akoya Biosciences	90	49.95 million	46.31 million	Optionable
FEIM Frequency Electronics	200	9.73 million	7.19 million	Not Optionable
KEQU Kewaunee Scientific	1,239	2.95 million	2.56 million	Not Optionable
MASS 908 Devices	60	35.86 million	27.36 million	Optionable

AKYA, FEIM, MASS, and KEQU Headlines

Recent News About These Companies

908 Devices (NASDAQ:MASS) Cut to Sell at Wall Street Zen

August 12 at 3:13 AM | americanbankingnews.com

908 Devices Inc. (NASDAQ:MASS) Receives Consensus Recommendation of "Buy" from Analysts

August 10 at 3:46 AM | marketbeat.com

908 Devices (NASDAQ:MASS) Downgraded by Wall Street Zen to "Sell"

August 10 at 2:56 AM | marketbeat.com

Leerink Partnrs Increases Earnings Estimates for 908 Devices

August 9 at 9:55 AM | marketbeat.com

908 Devices Inc. (NASDAQ:MASS) Receives Average Recommendation of "Buy" from Analysts

August 9 at 4:25 AM | americanbankingnews.com

908 Devices FY2025 EPS Forecast Raised by Leerink Partnrs

August 9 at 3:39 AM | americanbankingnews.com

908 Devices Inc. (NASDAQ:MASS) Analysts Are Pretty Bullish On The Stock After Recent Results

August 8, 2025 | finance.yahoo.com

Leerink Partnrs Upgrades 908 Devices (NASDAQ:MASS) to "Strong-Buy"

August 7, 2025 | marketbeat.com

Leerink Partners Upgrades 908 Devices (MASS)

August 7, 2025 | msn.com

908 Devices (NASDAQ:MASS) Releases Quarterly Earnings Results, Misses Expectations By $0.02 EPS

August 6, 2025 | marketbeat.com

908 Devices (NASDAQ:MASS) Raised to "Outperform" at Leerink Partners

August 6, 2025 | marketbeat.com

908 Devices Inc. (NASDAQ:MASS) Q2 2025 Earnings Call Transcript

August 6, 2025 | insidermonkey.com

908 Devices Inc. Reports Q2 Growth and Raises Outlook

August 6, 2025 | tipranks.com

908 Devices (MASS) Q2 Revenue Jumps 14%

August 5, 2025 | fool.com

Earnings To Watch: 908 Devices Inc (MASS) Reports Q2 2025 Result

August 5, 2025 | finance.yahoo.com

908 Devices Inc. (MASS) Q2 2025 Earnings Call Transcript

August 5, 2025 | seekingalpha.com

908 Devices Inc. (MASS) Reports Q2 Loss, Tops Revenue Estimates

August 5, 2025 | zacks.com

908 Devices Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Outlook

August 5, 2025 | businesswire.com

908 Devices Appoints Dr. Brandi Vann, former U.S. Principal Deputy Assistant Secretary for Nuclear, Chemical, and Biological Defense, to its Board of Directors

August 4, 2025 | businesswire.com

908 Devices (MASS) Projected to Post Quarterly Earnings on Tuesday

July 30, 2025 | marketbeat.com

908 Devices' (MASS) "Sell (D-)" Rating Reaffirmed at Weiss Ratings

July 30, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

AKYA, FEIM, MASS, and KEQU Company Descriptions

Akoya Biosciences NASDAQ:AKYA

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. It has a collaboration agreement with NeraCare that enables personalized therapy selection for early-stage melanoma patients. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

Frequency Electronics NASDAQ:FEIM

$31.29 +2.12 (+7.27%)

Closing price 04:00 PM Eastern

Extended Trading

$31.33 +0.04 (+0.13%)

As of 07:59 PM Eastern

Frequency Electronics, Inc., together with its subsidiaries, engages in designing, development, and manufacturing of precision time and frequency control products and components for microwave integrated circuit applications. It operates through two segments, FEI-NY and FEI-Zyfer. The FEI-NY segment offers precision time and frequency control products for communication satellites, terrestrial cellular telephone or other ground-based telecommunication stations; and other components and systems for the U.S. military; and provides design and technical support for satellite business. FEI-Zyfer segment offers global positioning system technologies to systems and subsystems for secure communications, both government and commercial, and other locator applications; and engages in sale and support of wireline telecommunications products, including US5G. It markets its products directly and through independent sales representative organizations located in the United States, Europe, and Asia. Frequency Electronics, Inc. was founded in 1961 and is headquartered in Mitchel Field, New York.

Kewaunee Scientific NASDAQ:KEQU

$56.50 +1.53 (+2.78%)

Closing price 04:00 PM Eastern

Extended Trading

$56.22 -0.28 (-0.50%)

As of 04:04 PM Eastern

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subidiaries, and a national distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.

908 Devices NASDAQ:MASS

$6.47 +0.04 (+0.62%)

Closing price 04:00 PM Eastern

Extended Trading

$6.48 +0.00 (+0.08%)

As of 07:52 PM Eastern

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time